
|Articles|May 12, 2022
Using the Science of Patient Activation to Reimagine Patient Support Practices
Author(s)Insignia Health
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
4
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
5